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Summary 
Flow cytometric and immunocytochemical analyses of murine fetal thymus (FT) cells with an- 
tibodies to various surface markers and transcription  factors reveal that the synthesis of TCF-1 
and GATA-3 proteins begins simultaneously in a fraction of the most immature population of 
FT  cells,  which  have  the  phenotype  of CD4-CD8-CD44+CD25  -.  No  TCF-l-producing 
cell is found in the fetal liver (FL). In CD44+CD25 -  FT cells, the production of TCF-1  is im- 
mediately followed by intracellular expression of CD3e. It is also found that the T  cell develop- 
ment from FL, but not FT, progenitors in the FT organ culture system is severely inhibited by 
the addition  ofantisense oligonucleotides  for either TCF-1  or GATA-3. These results strongly 
suggest that TCF-1  and  GATA-3 play essential roles in the initiation  of the earliest steps of T 
cell development in the thymus. 
T 
cells are produced mainly in the thymus from progen- 
itors  emigrated  from  extrathymic  hematopoietic  or- 
gans  (1-3),  although  it  is still  controversial  whether  these 
progenitors are prethymically committed to give rise to lym- 
phocytes or T  cells (2-4). In the murine fetuses, it is known 
that progenitors derived from fetal liver (FL) / or other fetal 
hematopoietic  organs  colonize  the  thymus  around  day  11 
of gestation  (5,  6),  and that the  differentiation  and growth 
of T  cells from these progenitors are induced  or supported 
by the  thymic microenvironment  (7).  The mechanisms  of 
TCR  gene rearrangement  and the  interaction  of maturing 
T  cells with the thymic microenvironment  through  TCR., 
so-called  positive  and  negative  selection,  are  becoming 
clearer (8, 9). On the other hand,  our knowledge about the 
earlier stages, during which the TCR  and coreceptors CD4 
and/or  CD8  have not yet been  expressed on  the  cell sur- 
face, is still fragmental. 
T  lineage cells in the fetal thymus (FT) that are negative 
for CD4 and CD8 can be divided into four subpopulations 
on  the  basis  of  CD44  and  CD25.  These  are  CD44 + 
CD25-,  CD44+CD25 +,  CD44-CD25 +,  and  CD44- 
CD25-,  and it is well known  that the  differentiation  pro- 
ceeds in this order (10,  11). It has been shown that progen- 
itors capable of generating B  and myeloid cells are present 
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lineage markers; KT, reverse transcription; S, sense. 
in fetal as well as adult thymuses (12-15).  These B  and my- 
eloid progenitors have not been well characterized,  and it is 
unclear  whether  thymic  B  and  myeloid  cells  are  derived 
from a common progenitor or stem cell that is also able to 
generate T  cells. In the murine fetus, the presence of B and 
myeloid progenitors has been shown in the FT at day 12 of 
gestation  (15),  and  the  phenotype  of day  12  FT is  exclu- 
sively CD44+CD25 -  (16). On the other hand, progenitors 
in  the  CD44+CD25 +  population  of FT,  which  is equiva- 
lent  to  the  c-kit+CD25 + population,  are  committed  to  T 
lineage (17). With adult thymocytes, it has been shown that 
the mlKNA for pre-TClLot (pTot) chain and all members of 
the CD3 complex are expressed at the CD44+CD25 -  stage 
(18,  19), and it has been suggested by Christiaan  et al.  (20) 
that  CD3~  proteins  are present  in  the  cytoplasm,  but  not 
on the surface of cells in this population.  Although  the ex- 
act role of intracellular  CD3e  (IC-CD3e)  in T  cell differ- 
entiation  has  not  been  clarified  so  far,  the  importance  of 
this molecule  is implicated by the finding that overexpres- 
sion  of human  CD3e  in  the  cytoplasm of murine  thymus 
cells causes a differentiation  arrest before entering into  the 
CD44+CD25 + stage  (21).  These findings  collectively sug- 
gest  that  if thymic  T  cell  progenitors  are  derived  from  a 
multipotent stem cell that has immigrated into the thymus, 
commitment to the T  cell lineage should occur during the 
CD44+CD25 -  stage. 
Whether  the  thymic  microenvironment  is inductive  or 
supportive,  stem cells or progenitors initiate  differentiation 
into  T  cells through  interaction  with thymic stromal cells. 
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the initiation ofT cell development is still unclear, involve- 
ment  of both  cell-to-cell and factor-mediated interactions 
has been shown by a variety of in vivo and in vitro experi- 
ments (17, 22-27).  It is probable that after interaction with 
thymic  stromal  cells,  the  progenitors  begin  to  produce 
transcription factors that are required for the expression of 
TCR  and related genes, such as CD3e.  Investigation of the 
production of lymphocyte-specific transcription factors may 
provide a  clue  to  elucidate the  mechanism  of the  earliest 
step of T  cell development. In the present study, we show 
that TCF-1  and GATA-3 are produced by a subpopulation 
of CD44+CD25 -  cells  shortly  before  the  production  of 
IC-CD3e, and that the addition of antisense (AS) oligonu- 
cleotides specific for these transcription factors in a FT or- 
gan culture system prohibits the T  cell development from 
prethymic progenitors. These findings strongly suggest that 
the production of these transcription factors is indispensable 
for commitment of stem cells to the T  lineage or for setting 
toward the  earliest differentiation of T  cells that  occurs at 
the CD44+CD25 -  stage. 
Materials  and Methods 
Mice and Organs 
C57BL/6  (B6) mice  were  purchased from Japan  SLC,  Inc. 
(Shizuoka, Japan)  and maintained in our animal facility. FT and 
FL were  obtained from  time-mated pregnant  mice  on  various 
days of gestation. The date of finding the vaginal plug was taken 
as day 0. Thymuses were also obtained from newborn and 4-wk-old 
B6 mice. B6Ly5.1 mice (maintained in our animal facility) were 
also used in organ culture experiments as the source of FT lobes 
into which B6 (Ly5.2) progenitors were seeded. 
Cell Lines 
Mouse teratoma line F9, mouse fibroblast line NIH3T3,  and 
SV-40-transformed monkey kidney cell li/ae Cos-7 were grown 
in DMEM supplemented with 10%} FCS. Mouse T  lineage lines 
EL4, BW5147, BgV (28), YT5  (cloned by Dr. H. Nariuchi, To- 
kyo University, Tokyo, Japan), mouse B lineage lines 70Z/3 and 
A20.2J,  mouse monocyte line P388,  and mouse myeloblast line 
M1  were  cultured in  RPMI  t640  medium supplemented with 
10% FCS. 
Reverse Transcription-PCR Assay 
RNA Isolation.  Total RNA was isolated from fetal, newborn, 
and adult thymuses by a  modification of the  acid guanidinium 
thiocyanate-phenol-chloroform (AGPC)  method  (29).  Thymus 
cells were washed with PBS and suspended into solution D  (4 M 
guanidinium thiocyanate, 25  mM  sodium citrate, 0.5%  sodium 
lauryl  sarcosine,  and  0.1  M  2-ME),  and  sheared  by  passage 
through a 21-gauge needle. The sheared lysate was mixed with 
0.1 vol of 2 M  sodium acetate, pH 4.0,  an equal volume of wa- 
ter-saturated phenol, and a 0.2 vol ofphenol-chloroform-isoamyl 
alcohol. After centrifugation, the  RNA  in  the  supematant was 
precipitated with isopropanol. Pelleted RNA was lysed again in 
solution D  and then precipitated with isopropanol, followed by 
washing with 70%  ethanol and drying up.  The  extracted RNA 
was dissolved in water, and the concentration was determined by 
spectrophotometric measurement. 
Reverse Transcription.  A mixture of RNA (1.0  p,g), 1 ml of 3 
mg/ml random primers (GIBCO BRL, Gaithersburg, MD), and 
water (total volume 26 ~1) was incubated at 65~  for 5 rain. After 
chilling on ice, 8 ~I of 5￿  reverse transcription (RT) buffer (0.25 
M  Tris-HC1, pH 8.3,  0.37 M  KC1, and 15 mM MgC12), 4 ~1 of 
0.1 M  DTT,  1 ILl of 100 rnM dNTPs, and 1 pA of M-MLV re- 
verse transcriptase (200  U/ml; GIBCO BRL)  were added. This 
reaction sample was incubated at 37~  for 60 rain and heated to 
95~  for 5 rain, then chilled on ice. To check for contamination 
of genomic DNA, the reaction was  also performed without re- 
verse transcriptase. 
PCR.  cDNA was  amplified by PCR  using various primers 
chosen on the basis of GENETYX-MAC program (Software De- 
velopment  Co.,  Tokyo,  Japan).  The  primers  used  included: 
GATA-3  sense  (S), 5'-TCGGCCATTCGTACATGGAA-3'; 
GATA-3 AS, 5'-GAGAGCCGTGGTGGATGGAC-3'; TCF-1 S, 
5'-GCCAGCCTCCACATGGCGTC-3'; TCF-1 AS, 5'-CGG- 
GTGAGGGATGGCTGCTG-3'; LEF-I  S,  5'-AACTCTGCG- 
CCACCGATGAG-3'; LEF-1 AS, 5'-AGAAAAGTGCTCGT- 
CGCTGT-3';  Ikaros S,  5'-AACGGCCTTTCCAGTGCAAC- 
3';  Ikaros AS,  5'-GTTGGCACTGTCATAGGGCA-3'; Sox-4 
S, 5'-GAGAACACTGAGGCTCTGCT-3'; Sox-4 AS, 5'-GGG- 
AGTCCGCACCTTGTAGA-3'; lck S,  5'-CATTCCCTTCA- 
ACTTCGTGG-3';  lck  AS,  5'-TAATGGCGGACTAGAT- 
CGTG-3'; 13-actin S, 5'-TCCTGTGGCATCCATGAACT-3'; 
13-actin AS, 5'-GAAGCACTTGCGGTGCACGAT-3'. The re- 
action volume was 10 ILl containing 1 I~1 ofcDNA sample, 1 ILl 
of 10￿  PCR  buffer  (500  mM  Tris-HC1,  pH  8.3,  2.5  mg/ml 
BSA, and 30  mM  MgC12), 200  IxM  dNTPs,  0.5  U  Taq  poly- 
merase (Wako Pure Chemical Industries, Osaka, Japan), and 100 
p~M of each primer. PCR amplification was performed in the Air 
Thermo-Cycler  TM  (Idaho  Technology,  Idaho  Falls,  ID)  under 
optimal rapid cycle PCR  condition (30,  31).  Cycling times and 
temperatures were as follows: denaturation at 94~  for 5 s, an- 
nealing at 57~  for 5 s, and elongation at 75~  for 30 s. The cycle 
number was 20 because the amplification was found to be within 
linear range (data not shown). Whole PCR product was electro- 
phoresed  through  a  gel  containing  4%  NuSieve  GTG  agarose 
(FMC Corp. BioProducts, Rockland, ME)  and 1% agarose,  and 
was blotted onto a nylon membrane. 
Southern Hybridizatiott.  Hybridization was performed as pre- 
viously described (32) with probes prepared from PCR products 
amplified with internally nested primers. The  hybridized men> 
branes were processed by an imaging analyzer (BAS  2000;  Fuji 
Photo Film, Tokyo, Japan). Radioactivity of the band represent- 
ing each PCR product was measured at the same time. 
Northern Hybridization 
All procedures were performed as previously described (32). 
Briefly, total RNA  (20  b~g) samples extracted from various cell 
lines and adult thymocytes by the modified AGPC method were 
subjected to electrophoresis, transferred onto a nylon membrane, 
and hybridized with TCF-1  or Ikaros cDNA probes labeled by 
random oligo priming (Megaprime DNA labeling system; Amer- 
sham International, Buckinghamshire, UK). 
Transient Transfection 
Coding regions of TCF-1 (33) and Ikaros (34) cDNA were in- 
serted into the BamHI site ofpNeoSRoL (35), and these recombi- 
nant plasmids were transfected to Cos-7 cells by electroporation, 
as described (32).  After incubation for 48  h  in DMEM,  whole- 
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Western blot analysis. 
Antibodies.  The following antibodies were used in this study: 
anti-erythroid lineage cell mAb TER119 (produced by T. Kina, 
Dept. of Immunology), anti-Mac-1 (M1/70, Caltag Laboratories, 
San Francisco, CA), anti-Gr-1 (RA3-8C5, PharMingen, San Di- 
ego,  CA), anti-B220 (RA-6B2; Caltag), anti-Thyl.2 (5a-8; Cal- 
tag),  anti-CD4 (GK1.5;  Caltag),  anti-CD8 (YTS169.4;  Caltag), 
anti-c-kit  (ACK-2)  (36), anti-CD44  (IM.7.8.1;  PharMingen), 
anti-CD25 (PC61; PharMingen), anti-CD3e (145-2C 11; PharMin- 
gen), and anti-human-GATA-3, which cross-reacts with mouse 
GATA-3 (HG3-31; Santa Cruz Biotechnology, Santa Cruz, CA). 
In cases where biotinylated reagents  were used as the first anti- 
body, APC-conjugated streptavidin (PharMingen) was added as a 
second-step reagent. 
Antibody Production, Western Blot Analysis and Immunocytochemis- 
try.  Polypeptides  of TCF-1 (amino acids 1-253) (33) and Ikaros 
(amino acids 1-432)  (34) were expressed in Escherichia coli using 
the  pET  vector  system  (37) and purified by  SDS-gel  electro- 
phoresis. Rabbits were subcutaneously injected with one of these 
peptides  emulsified with CFA, followed 4 wk later by a subcuta- 
neous injection of the  same  antigen emulsified  with  IFA.  Sera 
were harvested from these rabbits and checked for their antibody 
activity.  The sera showing high antibody activity were used for 
Western blot and immunocytochemical analyses. For flow cyto- 
metric analysis, the Ig fraction was purified from the sera by using 
a protein G column (Hi TrapTM protein G; Pharmacia Biotech, 
Uppsala,  Sweden),  and was conjugated with FITC as described 
(38). 
Nuclear extracts and cytoplasmic  fractions of various cell lines 
and  adult  thymocytes,  which  were  prepared  according  to 
Shreiber et al. (39), were subjected to Western blot analysis (38) 
using the rabbit antisera at a dilution of 1:500. Detection of anti- 
TCF-1 and anti-lkaros antibodies was accomplished  by incuba- 
tion of the immunoblots with a horseradish  peroxydase-conju- 
gated goat anti-rabbit IgG antibody (Zymed Laboratories,  South 
San Francisco, CA). 
FT cells and lineage marker negative (Lin-) FL cells were im- 
munocytochemically analyzed.  Lin-  FL  cells were  obtained as 
follows: FL cells from day 13 fetuses were reacted with TER119, 
Mac-l, Gr-1, and B220,  and the cells negative for these markers 
were sorted by a cell sorter (FACS  |  Vantage; Becton Dickinson & 
Co., Mountain View, CA).  Lin- FL cells and FT cells were set- 
tled onto slide glasses by cytocentrifugation (Cytospin 3; Shandon 
Scientific  Ltd.,  Chesire,  UK), fixed in 4% paraformaldehyde  for 
20 rain, washed in PBS, blocked in PBS containing 10% goat se- 
rum for 30 rain at room temperature, and incubated with the first 
antibody for 5 h in a humidified chamber at 4~  An FITC-con- 
jugated goat  anti-rabbit IgG antibody (Organon Teknika, Dur- 
ham, NC) was used for immunodetection. 
How Cytometric Analysis 
Surface  staining and flow  cytometric analysis of FT and FL 
cells were performed as previously described  (26). In analyzing 
the expression  of intracellular proteins, cells were fixed and per- 
mealized as described  (40). For two-color analysis for TCF-1 and 
GATA-3, FT cells were fixed by incubating in 100 ~1 of reagent 
A  (FIX & PEP,  M  cell permealization kit;  Caltag) for 15 rain at 
20~  washed  in PBS, and incubated in 50 btl of permealization 
reagent B (FIX & PER.M) containing FITC-anti-TCF-I and bi- 
otinylated anti-GATA-3 for  15  rain at  20~  The  cells  were 
washed again and reacted with APC-conjugated streptavidin.  For 
simultaneous detection of surface CD25 and intracellular proteins 
(TCF-1 and CD3e), FT cells were incubated with PE-anti-CD25, 
washed  in PBS,  and fixed  as  described  above.  The  cells were 
washed again and resuspended in 50 Ixl ofpermealization reagent 
B containing  a combination of APC-anti-CD3e and FITC-anti- 
TCF-1, or a combination of APC-anti-CD3e and FITC-rabbit 
IgG. These stained cells were analyzed by a FACS  |  Vantage. 
Sense and Antisense  Oligonucleotides 
AS  phosphorothioate  oligodeoxynucleotides were  designed 
against the translational  start region of TCF-1 and GATA-3 on 
the basis of the reported gene sequences  (33, 41).  As controls, 
complementary S oligonucleotides were created.  The sequences 
are  as  follows:  TCF-1  AS,  5'-CTCTTTGTACATGCCAC- 
TGGC-3'; TCF-1 S, 5'-GCCAGTGGCATGTACAAAGAG-3'; 
GATA-3  AS,  5'-CGCAGTCACCTCCATGTCCTC-3'; 
GATA-3 S, and 5'-GAGGACATGGAGGTGACTGCG-3'.  To 
determine the optimal concentrations of oligonucleotides that are 
not nonspecifically toxic but reduce the production of transcrip- 
tion factors, we initially  tested the effect of various concentrations 
of TCF-1 AS oligonucleotide on EL4 cells. A final concentration 
of 100 ~xg/ml was used in organ cultures because this concentra- 
tion of oligonucleotide partially reduced the expression of TCF-1 
protein in EL4  cells without affecting the growth of these  cells 
(data not shown). 
High Oxygen Submersion (HOS) Culture 
The basic procedure for HOS culture has been described pre- 
viously  (42, 43).  In  short,  RPMI1640  medium supplemented 
with 10% FCS, sodium pyruvate (1 mM), sodium bicarbonate (2 
mg/ml), nonessential amino acid solution (1  raM), 2-ME  (5  ￿ 
10 -5 M), streptomycin (100 Ixg/ml),  and penicillin (100 U/ml) 
was used as complete medium. FT lobes obtained from day 15 fe- 
tuses  of  B6Ly5.1  mice  were  cultured  with  deoxyguanosine 
(dGuo; 1.35 raM) for 6 d to deplete T lineage cells and their pre- 
cursors from the lobe. Single dGuo-treated lobes were submerged 
in 0.2 ml of complete medium in a well of a 96-well U-bottom 
plate  (Costar  Corp., Cambridge, MA). Lin-c-kit  + FL cells (103) 
or c-kit + FT cells (103) isolated from B6 mice by sorting with a 
FACS |  Vantage  were inoculated into each well.  S or AS oligo- 
nuculeotides (final concentration =  100 Izg/ml)  for TCF-1 and 
GATA-3, or the  1:1  mixture (total  =  100  b~g/ml) of these  AS 
oligonucleotides,  were  added  to  each  well.  The  plates  were 
placed  into a plastic bag (Ohmi Oder Air Service,  Hikone, Ja- 
pan),  and the air was exchanged with a gas mixture of 5% CO2, 
70% 02, and 25% N 2. The plastic bag was incubated in a 37~ 
incubator.  On  day  3  of culture,  half of the  medium was  ex- 
changed with fresh complete medium containing  the correspond- 
ing oligonucleotides. Cells in the lobes were harvested  on day 5 
of culture, enumerated, and surface profiles of these cells were an- 
alyzed by a FACS  |  Vantage. 
Results 
Semiquantitative  RT-PCR  Analysis  of the  Transcription of 
Nuclear Protein Genes in FT.  We first investigated the  ex- 
pression levels of several transcription factors that are known 
to  be  involved in  the  transcription of TCP,.  and  related 
genes. RNA was extracted from the thymus cells of fetuses 
at various gestational ages, and was used in a RT-PCR. as- 
say. Amplification was done for 20 cycles because prelimi- 
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Figure  1.  RT-PCR analysis of the  expression of transcription factor 
genes in FT cells. RNA was prepared from thymus cells of fetuses at days 
12, 13, 14, 15, 16, and 18 of gestation, as well as of newborn and 4-wk-old 
mice.  1 Itg of RNA was reverse-transcribed, and the cDNA was ampli- 
fied for 20 cycles with primers specific for each transcription factor gene. 
After RT-PCR, the products were subjected to Southern blot analysis.  As 












1.25  - 
:E 
(D 
>  1.0-  ,I 
0.75  -  CE 
0.5- 
0.25  - 
0  - 
Figure  2. 
k 
~  GATA-3  i 
t  - ~-  TCF-1  / 
A--if 
i  l  i  i  I  i  I  i  a 
[~.. {3...0 .. 0...0 
--~--  LEF-1 
A  Sox-4 
.... D..-  Ikaros 
l  l  I  l  I  l  l  I 
Relative  message levels of various transcription factors ex- 
pressed in thymus cels from fetuses at different gestational ages. The signal 
intensity of Southern blot analysis  bands in Fig. 1 was measured by an im- 
aging analyzer and normalized by that of [3-actm. The normalized signal 
intensity corresponding to adult thymus cells in each transcription factor 
gene was set as 1.0, and the  relative values of newborn and fetal mice 
were plotted. 
nary experiments indicated that the amount of PCR  prod- 
uct  was  approximately  proportional  to  the  amount  of 
original mRNA  with this cycle number (data not shown). 
RT-PCR  products  were  hybridized  with  the  probe  spe- 
cific for each gene (Fig.  1), and the relative amounts of the 
product determined as the signal intensity of bands in Fig. 1 
are plotted in Fig. 2 in reference to the age of the mice. All 
the genes examined are more or less expressed in the thy- 
mus as early as day 12 of gestation. Two major bands, each 
seen in cases of TCF-1 and Ikaros, are caused by the design 
of PCR  primers encompassing an exon that can be spliced 
out. According to  the expression profile in FT, these tran- 
scription factors  can be  divided into two  groups.  The  first 
group  comprises  GATA-3  and TCF-1, which have previ- 
ously been shown to be T  lineage specific (33, 44, 45). The 
expression levels of these two genes steeply increase during 
early-  to  mid-gestational  age,  suggesting  that  they  play 
some roles in the early phase  of T  cell differentiation. The 
second  group  comprises  LEF-1  (46,  47),  Sox-4  (48,  49), 
and Ikaros (34), and these genes are expressed at high levels 
as early as day  12 of gestation, and the levels are constantly 
maintained until adult age. 
Rabbit Antibodies  against TCF- 1 and Ikaros.  Although the 
RT-PCR  experiments indicated that TCF-1  and GATA-3 
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cytes  with  anti-TCF-1  and  anti-Ikaros.  Whole-cell  lysates  of Cos-7, 
TCF-l-transfected  Cos-7  (Cos-7 TCF-1) and  Ikaros  transfected  Cos-7 
(Cos-7 lkaros), and nuclear extracts  from a teratoma cell line (F9), a fibro- 
blast  cell line  (NIH3T3), T  lineage  cell lines  (EL4, BW5147,  YT5, and 
BgV),  B  lineage  cell  lines  (70Z/3  and  A20.2j)  and  myeloid  cell  lines 
(P388 and  MI),  and  adult  thymocytes were size-fractionated  by  SDS- 
PAGE.  The  electrophoresed lysates or nuclear extracts  were transferred 
onto  a  nylon  membrane,  and  were  reacted  with  anti-TCF-1  or anti- 
lkaros serum at a dilution of 1:500.  The sizes of molecular mass markers 
are indicated  in kilodaltons.  Preimmune rabbit sera do not show any band 
(data not shown). 
began to be produced at a very early stage of T  cell devel- 
opment, these experiments could not clarify whether these 
nuclear proteins were produced by a small number of day 
12 FT or day 13  FT cells,  or they were produced in small 
amounts by all the FT cells.  Immunocytochemical and flow 
cytometric  investigations  would  be  effective in  clarifying 
this point and also  identifying the differentiational stage of 
thymocytes at which  these nuclear factors are first synthe- 
sized.  Anti-human  GATA-3  mAb  can  be  used  to  detect 
mouse  GATA-3  and  is  commercially available,  but  anti- 
TCF-1 is unavailable so far. 
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Figure 4.  Northern blot analysis for expression of TCF-1 and Ikaros in 
various cell lines and adult  thymocytes. Total RNA (20 Ixg) from various 
cell lines and adult thymocytes was size-fractionated  by gel electrophore- 
sis, transferred  onto a nylon membrane, and hybridized with a probe of 
the coding region of TCF-1  or Ikaros cDNA. 
We  raised  rabbit  antibodies  to  TCF-1  and  also  Ikaros 
(for details see Materials and Methods),  the latter of which 
has been shown to be expressed by all lymphocytes, includ- 
ing FT  cells  and lymphoid progenitors  (34).  Western blot 
analysis  was performed with  whole-cell  lysates or nuclear 
extracts of various cell lines and adult thymus cells  (Fig.  3). 
28- and 48-kD bands are clearly seen in Cos-7 cells trans- 
fected  with  TCF-1  and  Ikaros  cDNA,  respectively.  No 
anti-TCF-l-reactive  band  was  observed  in  untransfected 
Cos-7 cells, a teratoma line F9, a fibroblast line NIH3T3, B 
lineage lines 70Z/3 and A20.2J, a monocyte line P388, or a 
macrophage/granulocyte precursor line M1.  On the  other 
hand,  the anti-TCF-1  antiserum detected several bands in 
two  (EL4  and  BW5147)  out  of four  T  lineage  lines  and 
adult  thymocytes.  The  28-kD  band  represents  the  same 
protein  as  that  produced  in  Cos-7  cells  transfected  with 
TCF-1  cDNA. On the other hand, it has not exactly been Figure S.  lmmunocytochemical staining of FT cells and Lin- FL cells with anti-TCF-1 and anti-Ikaros. FT cells from days 12, 13, and 16 fetuses  and 
FACS|  Lin- FL cells from day 13 fetuses  were reacted with anti-TCF-1, anti-Ikaros, or normal rabbit serum (Control) at a dilution of 1:500, and 
stained by FITC-conjugated goat anti-rabbit IgG. Photomicrographs: ￿  Percentages  of TCF-1 + and Ikaros  + cells, as determined by inspection of 
> 1,000 cells, is demonstrated at the lower right edge of each photograph. Flow cytometric profiles for c-kit  vs Lin markers (TER.119, Mac-1, Gr-1, and 
B220) on day 13 FL cells, and those for c-kit  vs T lineage markers (Thy-1, CD4, and CD8) on FT cells, are shown at the lowest lane. The percentage of 
cells that fall into each quadrant is indicated. 
determined whether other bands represent the products of 
alternative splice forms ofmRNA  or other unknown cross- 
reactive  proteins.  However,  circumstantial  evidence  in- 
cluding  the  fact  that  protein  bands  are  observed  only  in 
cells  positive  by  Northern  blot  analysis  (Fig.  4)  strongly 
suggests that the larger and smaller proteins are the products 
of alternative splice forms of TCF-1  (see Discussion). 
Proteins reactive with anti-Ikaros are produced by hll he- 
matopoietic  cell  lines  and  adult  thymocytes,  and  one  of 
these proteins is the same as that produced in cDNA trans- 
fected Cos-7  cells  (Fig.  3).  One  to  three  other bands  are 
also seen in all these cell lines and thymocytes. Because no 
band is observed in nonhematopoietic lines that are nega- 
tive by Northern  blot  analysis (Fig.  4)  and  the  molecular 
weights of the detected proteins correspond to those of al- 
ternative splice forms  of Ikaros  (50),  it is highly probable 
that every band represents a product of the Ikaros gene. 
Detection of TCF-l-producing  Cells in  FT by  Immunocy- 
tochemical Staining.  FT  ceils from fetuses of various gesta- 
tional ages and FACS|  Lin- FL ceils from day 13 fe- 
tuses  were  settled  on  slide  glasses  by  cytocentrifugation. 
Cells  were  indirectly  stained  with  anti-TCF-1  and  anti- 
Ikaros antisera, as described in Materials and Methods,  and 
the fluorescence micrographs are shown in Fig. 5. Flow cy- 
tometric profiles of surface staining of the  same  cells with 
anti-c-kit  and  anti-Lin markers  are  also  shown.  The  ex- 
pression of the lkaros protein was observed in about half of 
the Lin- FL cells and in virtually 100% of FT cells. On the 
other  hand,  no  TCF-l-positive  cell  was  found  in  FL. 
About 30% of day 12 FT cells were positive for TCF-1  ex- 
pression, and the  proportion TCF-1 +  ceils increased with 
gestational age to reach "-q00%  on day 16. The expression 
of TCF-1 in FT cells is not directly correlated with the sur- 
face expression of Thy-1, CD4, and CD8. 
Expression of TCF-1  and  GA TA-3  before Intracellular Ex- 
pression of CD3e.  As has previously been characterized (16), 
all day 12 FT cells show a phenotype of CD4-CD8-  c-kit  + 
CD44+CD25 -  and do not express CD3~  on their surface. 
Day  13  FT  cells are  CD3e-  and a  large majority of these 
cells are  still c-kit  +,  whereas  about  a  quarter  of them  ex- 
press  CD25.  The  data confirming these  previous findings 
are shown in Fig. 6 A  and Fig. 7, A  and B. Since immuno- 
cytochemical  experiments  in  the  preceding  section  indi- 
cated that ~30% of day 12 FT cells were positive for TCF-1 
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Figure 6.  Flow cytometric analysis for the intracellular expression of 
TCF-1, GATA-3, and CD3e in day 12 FT cells. (A) Surface expression 
profiles for CD3e vs CD4 and CD8, c-kit vs CD44, and c-kit vs CD25. 
(B)  Intracellular expression of CD3~. The shaded histogram represents 
background staining with APC-streptavidin. (C) Two-color staining pro- 
file for TCF-1 vs GATA-3.  tn this experiment, fixed and permeatized 
cells were reacted with biotinylated anti-GATA-3 followed by staining 
with APC-conjugated streptavidin and FITC-anti-TCF-1. 
(Fig.  5),  day  12  FT  cells  were  thought  to  be  useful  for 
comparing the expression of TCF-1  with that of GATA-3 
or IC-CD3~. Day 12 FT cells were fixed, permeahzed, and 
stained with  anti-CD3e  or dual stained with  anti-TCF-1 
and anti-GATA-3. The results are shown in Fig. 6, B and C. 
About 20%  of the  cells were  positive for  IC-CD3e.  The 
profile  of  double  staining  with  anti-TCF-1  and  anti- 
GATA-3  indicated  that  these  two  transcription  factors 
were produced in the same cells of~30%  of day 12 FT. 
A  more detailed investigation to identify the phenotypes 
of cells expressing TCF-1  was performed with day  13  FT 
cells, because day 13  FT cells are still CD4-CD8-CD3e-, 
but they begin to express CD25  (Fig. 7, A  and B). For in- 
vestigating TCF-1  expression, three-color analysis was per- 
formed with FITC-anti-TCF-1, APC-anti-CD3~, and PE- 
anti-CD25.  The results shown in Fig. 7  C  strongly suggest 
that  CD3~  proteins are  produced  after the  production  of 
TCF-1. The expression of IC-CD3e, however, is not nec- 
essarily related to  the  surface  expression of CD25  (Fig.  7 
D),  and day  13  FT  cells can be divided into four popula- 
tions  of  CD25-IC-CD3e-,  CD25+IC-CD3e -,  CD25- 
IC-CD3e +,  and  CD25+IC-CD3~ +.  The  expression  of 
TCF-1  in these populations is shown in Fig. 7  E.  It can be 
seen that a small proportion of CD25-IC-CD3e-  cells ex- 
press  TCF-1  at  low  levels,  whereas  all  cells in  the  other 
populations express this nuclear protein at high levels. We 
also found that the expression profile of GATA-3 in these 
four subpopulations was virtually the same as that of TCF-1 
(data not shown). 
Inhibition  ofT Cell Development in FT Organ  Cultures by AS 
Oligonucleotides for TCF- I and GA TA-3.  Experiments  were 
undertaken  to  examine whether  TCF-1  and  GATA-3 play 
any role in T  cell development.  Lin-c-kit + cells from day 
13 FL or c-kit + cells from day 13 FT were isolated and cul- 
tured with dGuo-treated FT lobes in the presence of S  or 
AS oligonucleotides for these transcription factors. Groups 
given no  oligonucleotides or S  oligonucleotides were  also 
set up in parallel. Cells were harvested on day 5 of culture, 
enumerated, and assayed for expression of surface markers. 
The results shown in Table  1 indicate that T  cell develop- 
ment from FL progenitors is severely inhibited by the addi- 
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Figure  7.  Flow  cytometric 
analysis for  comparing  the  ex- 
pression levels of  TCF-1 and IC- 
CD3e  in  day  13  FT  cells. (.4) 
Surface  expression profile  for 
CD3e  vs  CD4  and  CDS.  (B) 
Surface  expression profile  for 
c-kit  vs  CD25.  (C)  Two-color 
staining profile for IC-CD3e vs 
TCF-1. (D) Two-color staining 
profile for surface CD25 vs IC- 
CD3e.  The  percentage of cells 
falling into each quadrant is indi- 
cated in the inset of each panel 
(A-D). (E) Expression profiles of 
TCF-1  in cells included in areas 
R1,  IL2, R3,  and RA gated on 
D.  Shaded histograms represent 
background staining with FITC- 
conjugated normal rabbit IgG. 
1143  Hattori et al. Table 1.  Inhibition of T  Cell Development in Organ Cultures by AS  Oligonudeotides for GA TA-3 and TCF- 1 
Progenitor cells* 
Percentage in Thy-1 + cells 
No. of recovered Thy- 1  + 
Oligonucleotider  cells per lobe ( ￿  103)  CD4- CD8  CD4 +  CD8 + 
FL Lin-c-kit  + cells (103) 
FT c-kit  + cells (5 X 102) 
None  5.0  98  0 
GATA-3(S)  4.5  96  0 
GATA-3(AS)  0.8  96  0 
TCF-I(S)  4.8  98  0 
TCF-I(AS)  1.0  97  0 
GATA-3  (S) +TCF-1 (S)  4.0  98  0 
GATA-3(AS) +TCF-I(AS)  0.I  98  I) 
None  24.0  44  24 
GATA-3(S)  20.0  40  21 
GATA-3(AS)  10.0  64  11 
TCF-I(S)  21.0  42  22 
TCF-I(AS)  12.0  51  11 
GATA-3+TCF-I(S)  19.0  43  20 
GATA-3(AS)  +TCF-I(AS)  9.5  56  9 
*Lin-c-kit  + population of day 13 FL cells or c-kit  + population of day 13 FT cells were cultured under HOS conditions together with a dGuo- 
treated FT lobe in a U-bottom well for 5 d. The number of  progenitors cultured with a lobe is shown in the parenthesis. 
*S or AS oligonucleotides were inoculated into the well at the final concentration of 100 Ixg/ml. In cases where S or AS oligonucleotides for both 
GATA-3 and TCF-1 were added, the final concentration of each oligonucleotide was 50 I.tg/ml. 
GATA-3.  Moreover,  T  cell  development  is  completely 
abolished by the addition of both AS oligonucleotides.  On 
the  other hand,  the  effect  of these  AS oligonucleotides  is 
only slight,  if any,  on  T  cell  generation  from day  13  FT 
c-kit  + cells,  which contain cells  already expressing TCF-1 
and  GATA-3. Similar results were obtained when the  or- 
gan culture was continued for 8 d  (data not shown). These 
results strongly suggest that TCF-1 and GATA-3 are indis- 
pensable  for  the  very  early  stages  of differentiation  and 
growth ofT lineage cells. 
Discussion 
The present  study showed that  the  transcription  factors 
TCF-1  and GATA-3 were produced by ,'~30% of the cells 
in  the  CD44+CD25 -  population  of FT,  which  has  been 
known as the most immature subset,  and that the produc- 
tion  of these  nuclear  proteins  is  immediately  followed by 
the intracellular expression  of CD3e.  It was further shown 
that  the  AS  oligonucleotides  for  TCF-1  or  GATA-3  se- 
verely inhibited  the  T  cell development  from progenitors 
in FL, but not FT, indicating that these transcription factors 
play a critical role in a very early phase of T  cell develop- 
ment. 
The finding that TCF-1  and GATA-3 begin to be pro- 
duced by "~  of the  most immature  subset  of FT  cells 
was made by flow cytometric analysis in which antibodies 
to  these  transcription  factors  were  used  for  intracellular 
staining. Anti-GATA-3 mAb used in the present work has 
been produced by immunizing a mouse with recombinant 
human  GATA-3  protein  (51),  and  this  mAb  cross-reacts 
with  mouse  GATA-3.  Anti-TCF-1  produced  by immu- 
nizing a rabbit with the recombinant mouse TCF-1 protein 
exhibits  several protein  bands  other than  that  correspond- 
ing  to  the  protein  used  for  immunization  of a  rabbit.  It 
seems unlikely that these bands represent  cross-reactive ir- 
relevant proteins for the  following reasons:  (a)  no reactive 
bands  were  seen  in  non-T  lineage  cell  lines  (Fig.  3);  (b) 
none of the protein  bands was detected in T  lineage lines 
YT5  and  BgV  that  showed  no  detectable  band  in  the 
Northern  blot analysis  (Figs.  3  and  4);  (c)  the  presence  of 
several alternative splice forms ofTCF-1 mRNA  is known 
(reference 33 and see Fig. 4); and (d) addition of AS oligo- 
nucleotides for TCF-1 into the culture of EL4 cells resulted 
in a reduction of the density of all bands to the same extent 
(data not shown). For these reasons, we regard that all these 
protein  bands  represent  the  products  of alternative  splice 
forms ofTCF-1. On the other hand, since our anti-TCF-1 
does not discriminate between these proteins  and we have 
not identified the protein(s) produced by FT cells,  so far, it 
is unclear which of these proteins is critical for early T  cell 
differentiation. 
It has not been clarified whether the commitment ofhe- 
matopoietic  stem  cells  to  the  T  lineage  occurs prethymi- 
cally or in  the  thymus.  Previous  studies  using genetically 
marked bone marrow cells  (52,  53)  suggested a prethymic 
commitment to the T  lineage.  In these studies, however, a 
possibility cannot be excluded that genetically marked mul- 
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to develop exclusively into T  cells. On the other hand, the 
presence in the thymus of progenitors capable of generating 
B  cells  (13,  14)  and myeloid cells  (12,  15)  has  repeatedly 
been shown,  suggesting that the  progenitors immigrating 
into the  thymus retain the  multipotent stem cell activity. 
These  findings,  however,  do  not  formally  preclude  the 
possibility that T lineage commitment occurs before immi- 
grating into the thymus because it is possible that all three 
types of progenitors precommitted to the T, B, or myeloid 
lineage immigrate into the  thymus.  Trials to discriminate 
between prethymic and intrathymic progenitors on the ba- 
sis of their surface phenotype were unsuccessful, since it is 
hard  to  exactly identify or isolate these progenitors.  It is 
only possible to compare progenitor cell-enriched popula- 
tions from FL, adult bone marrow,  FT, or adult thymus, 
and the phenotypes of these progenitor cell-enriched pop- 
ulations  from different sources resemble each  other quite 
well (14, 26, 54). 
Regardless of the similarity in phenotypes of progenitors 
from different sources, the T  cell-producing activity of these 
progenitors is markedly different from each other. For ex- 
ample, a nearly two times longer period is required for FL 
progenitors than for FT progenitors to give rise to T  cells 
when  cocultured  with  a  dGuo-treated  FT  lobe  (Kawa- 
moto, H., N. Hattori, and Y. Katsura, manuscript in prep- 
aration).  A  larger difference has  been shown to  exist be- 
tween  progenitors from  adult  bone  marrow  and  thymus 
(14,  55, 56).  Since "thymus-type" progenitor cells,  which 
are able to generate T  cells within a few days,  have never 
been detected in bone marrow or FL (56, 57; Kawamoto, 
H., N. Hattori, and Y. Katsura, manuscript in preparation), 
it is probable that a very small number of multipotent stem 
cells that constantly generate thymus-type progenitors exist 
in the thymus. If this is the case, the prethymic progenitors 
or stem cells that immigrate into the thymus may immedi- 
ately be induced to generate thymus-type progenitors, al- 
though such a dramatic change of progenitor activity has 
not been correlated with  a  change in  surface phenotype. 
The  present  study  showed  that  synthesis  of TCF-1  and 
GATA-3 occurred in a subpopulation of the most imma- 
ture subset of FT cells before the production of the CD3e 
protein. The production of these nuclear proteins could be 
used as  the  earliest differentiation markers.  On  the  other 
hand,  the subpopulation of CD44+CD25 -  cells that have 
not yet expressed these transcription factors may be even 
more primitive. Further investigation is in progress to elu- 
cidate  the  relationship  between  the  expression  of these 
transcription factors and commitment to the T lineage. 
AS  oligonucleotides for either TCF-1  or GATA-3 in- 
hibited T  cell generation from FL progenitors in  the  FT 
organ culture system. The inhibitory effect of TCF-1  AS 
oligonucleotides conforms to the recent finding that in the 
TCF-1 null mutant mice, the numbers ofthymocytes is re- 
duced 10-100-fold, compared to wild type littermates (58). 
The  importance  of GATA-3  in  the  hematopoiesis  was 
shown in GATA-3 knockout mice (59),  in which the he- 
matopoiesis in FL is severely impaired. The present finding 
that the suppressive effect was much stronger when AS oli- 
gonucleotides for both TCF-1  and  GATA-3 were added 
strongly suggests  that these two transcription factors coop- 
erate in early T  cell differentiation. On the other hand, the 
inhibitory effect of AS oligonucleotides on T  cell develop- 
ment from FT progenitors was only slight,  and the inhibi- 
tion was not strengthened by the addition of AS oligonu- 
cleotides for both TCF-1 and GATA-3. As seen in Fig.  7, 
c-kit  + FT cells used as progenitors in this  experiment in- 
clude  cells  already producing TCF-1  and  GATA-3  pro- 
teins. These thynfic progenitors may be resistant to treat- 
ment with the AS oligonucleotides for their differentiation 
and growth. 
It has been shown that TCF-1 binds to the enhancer of 
CD3e  (33),  whereas  no  GATA-3-binding  site  has  been 
discovered in the enhancer region of the CD3e gene. Al- 
though a GATA-3-binding site  exists  in the enhancers of 
TCRI3, TCRS, TCRot, CD4, and CD8 genes (60,  61), it 
seems improbable that the production of GATA-3 protein 
is required at the CD44+CD25 -  stage,  since no transcript 
of these genes has  ever been detected at this  or the  next 
CD44+CD25 + stage  (10).  Identification of the target(s)  of 
GATA-3 as well as TCF-1 will be one of the most impor- 
tant steps for elucidating the molecular mechanism of early 
T  cell differentiation. Various transcription factors, includ- 
ing LEF-1 (46, 47, 62), Sox-4 (49), and Ikaros (34) investi- 
gated in the present work, are expressed at very early FT. 
Although the expression of these molecules is not necessar- 
ily  T  lineage  specific,  it  is  probable  that  they  cooperate 
with TCF-1 and GATA-3. Studies are in progress to clarify 
the cooperation of transcription factors in T  cell develop- 
ment. 
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